The Initial Focus Will Be Clinical Studies of the Company’s Prana Product Line
DENVER, CO / ACCESSWIRE / January 30, 2017 / United Cannabis Corporation (CNAB) (the “Company” or “United Cannabis”) today announced that it, along with its Jamaica-based subsidiary, Cannabis Research Development (“CRD”), has signed a Letter of Intent (the “LOI”) with the Caribbean Institute of Medical Research (“CARIMER”) to collaborate on advancing clinical research on medical cannabis.
CARIMER is the Jamaican-based division of MPR Development Group, a full service global Clinical Research and Development Organization (“CRO”). CARIMER also serves as the research arm of several medical facilities and hospitals in the Caribbean and collaborates with health institutions to support health care research projects around the world.
According to the terms of the LOI, studies will be conducted under the supervision